EGM
IOVA icon

Engineers Gate Manager’s Iovance Biotherapeutics IOVA Stock Holding History

Engineers Gate Manager’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$791K Buy
190,035
+82,338
+76% +$313K 0.01% 1224
2026
Q1 		$378K Sell
107,697
-86,994
-45% -$278K ﹤0.01% 1581
2025
Q4 		$532K Buy
+194,691
New +$450K 0.01% 1329
2023
Q4 		– Sell
-22,908
Closed -$104K – 2091
2023
Q3 		$104K Buy
+22,908
New +$150K ﹤0.01% 1600
2023
Q2 		– Sell
-10,940
Closed -$66.8K – 1872
2023
Q1 		$66.8K Sell
10,940
-9,580
-47% -$66.1K ﹤0.01% 1540
2022
Q4 		$131K Sell
20,520
-10,445
-34% -$81.5K 0.01% 1452
2022
Q3 		$297K Buy
30,965
+18,316
+145% +$211K 0.02% 1122
2022
Q2 		$140K Buy
+12,649
New +$166K 0.01% 1695

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Engineers Gate Manager's IOVA Position: Q2 2026 in Review

Engineers Gate Manager increased its Iovance Biotherapeutics (IOVA) stake by 76% in Q2 2026, buying an estimated $313K and bringing the position to 190,035 shares worth $791K. The position accounts for 0.01% of the portfolio, ranked #1224.

Engineers Gate Manager first reported a position in IOVA in Q2 2022 and has held it in 8 quarters since. 292 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

  • Engineers Gate Manager held 190,035 shares of Iovance Biotherapeutics worth $791K as of Q2 2026.
  • Engineers Gate Manager bought 82,338 Iovance Biotherapeutics shares in Q2 2026, an estimated $313K.
  • Iovance Biotherapeutics made up 0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #1224 holding.
  • Engineers Gate Manager first reported a position in Iovance Biotherapeutics in Q2 2022 and has held it in 8 quarters since.
  • 292 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.